Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma

In order to achieve a better outcome for pancreatic cancer patients, reliable biomarkers are required which allow for improved diagnosis. These may emanate from a more detailed molecular understanding of the aggressive nature of this disease. Having previously reported that Notch3 activation appeare...

Descripción completa

Detalles Bibliográficos
Autores principales: Mann, Christopher D., Bastianpillai, Christopher, Neal, Christopher P., Masood, Muhammad M., Jones, Donald J. L., Teichert, Friederike, Singh, Rajinder, Karpova, Elena, Berry, David P., Manson, Margaret M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514220/
https://www.ncbi.nlm.nih.gov/pubmed/23226563
http://dx.doi.org/10.1371/journal.pone.0051119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514220/
https://www.ncbi.nlm.nih.gov/pubmed/23226563
http://dx.doi.org/10.1371/journal.pone.0051119

Ejemplares similares